Tonix Pharmaceuticals (TNXP) Insider Taylor Buys $15K of Stock
Carolyn Taylor bought 1,415 shares of TNXP at $10.55 per share on June 12, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
Carolyn Taylor bought 1,415 shares of Tonix Pharmaceuticals Holding Corp. ($TNXP) at an average price of $10.55, worth about $14,928.25, on June 12, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $TNXP is up 7.5% after 1 week, up 3.2% after 1 month and down 46.8% to date (from the $11.35 close on Jun 12, 2026).
TNXP
Tonix Pharmaceuticals Holding Corp.
Key Points
- Carolyn Taylor purchased 1,415 shares of TNXP at $10.55 each on June 12, 2026, for a total of $14,928.25.
- Shares of TNXP traded at $11.35, with a recent insider buying spree by several executives.
- Analysts at TD Cowen initiated coverage on TNXP with a 'buy' rating and a $22 price target on May 4, 2026.
Get $TNXP trade alerts by text
We text you when insiders, Congress or big funds trade $TNXP. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Tonix Pharmaceuticals Holding Corp. alert may contain errors. Disclosures
Carolyn Taylor made a significant move by purchasing 1,415 shares of TNXP on June 12, 2026. She paid $10.55 per share, bringing her total investment to $14,928.25. This transaction was not part of a pre-arranged trading plan.
Insider Buying and Selling at Tonix Pharmaceuticals Holding Corp.
Several insiders have been active in buying TNXP shares recently. On June 9, 2026, CEO Seth Lederman acquired 5,000 shares at $11.79 each. Just a day before, on June 8, Richard Newcomb Stillwell bought 5,000 shares at $11.65 per share. Additionally, in May, Richard Bagger, Richard Newcomb Stillwell, and David Grange each bought 22,700 shares, although the price for these transactions was not disclosed.
Other Institutional Activity in TNXP
Institutional investors have shown interest in TNXP as well. BlackRock, Inc. increased its holdings by 83,296 shares, ending with 968,177 shares valued at about $13.31 million. Vanguard Capital Management LLC added 518,650 shares, now holding the same amount worth approximately $7.13 million. Citadel Advisors LLC also picked up 468,712 shares, valued at around $6.44 million. Jones Hill Capital LP matched this move with 452,116 shares, valued at $6.22 million. Geode Capital Management, LLC upped its stake by 41,387 shares, totaling 313,291 shares valued at $4.31 million. Balyasny Asset Management L.P. made a substantial increase of 127,730 shares, bringing its total to 313,082 shares worth $4.30 million.
Analysts Set New Price Targets
On May 4, 2026, TD Cowen initiated coverage on TNXP with a 'buy' rating and set a price target of $22. Noble Capital Markets reiterated its 'buy' rating with a target price of $70 back in March 2025. Alliance Global Partners maintained its 'buy' rating with an $11 target as of July 2024.
Bottom Line
Carolyn Taylor's purchase of TNXP shares is part of a broader trend of insider buying, which may suggest confidence in the company's future. The stock, trading at $11.35, has seen increased interest from both insiders and institutions. Analysts have also shown optimism, with several firms maintaining 'buy' ratings and setting ambitious price targets. As always, while these insights provide a snapshot of recent activity, they reflect past decisions and may not indicate future performance.
Related Filing Alerts
Source: Carolyn Taylor's Form 4 filing on $TNXP (Jun 12, 2026). Find the original filing: TNXP Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts